AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00
- £28.33m
- £21.92m
- £4.57m
REG - Arecor Therapeutics - ARECOR STRENGTHENS COLLABORATION WITH PARTNER
AnnouncementRCS - Arecor Therapeutics - Arecor Publishes Data for AT278 in Diabetes Care
AnnouncementREG - Arecor Therapeutics - BUSINESS UPDATE
AnnouncementREG - Arecor Therapeutics - ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA SERVICE AGREEMENT WITH SYNEOS HEALTH
AnnouncementREG - Arecor Therapeutics - Grant of LTIP Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - ARECOR TO COMMENCE SECOND TRIAL WITH AT278
AnnouncementREG - Arecor Therapeutics - ARECOGRANTED PATENT IN JAPAN AND SOUTH KOREA
AnnouncementREG - Arecor Therapeutics - Grant of AESOP Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - SPECIALTY HOSPITAL FORMULATION COLLABORATION
AnnouncementREG - Arecor Therapeutics - Exercise of options and PDMR dealing
AnnouncementREG - Arecor Therapeutics - TETRIS PHARMA LAUNCHES OGLUO® IN GERMANY
AnnouncementREG - Arecor Therapeutics - Headline results from Phase I trial of AT247
AnnouncementRCS - Arecor Therapeutics - Arecor Presents Positive Data for AT278 at EASD
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2022
AnnouncementREG - Arecor Therapeutics - Notice of Interim Results
AnnouncementREG - Arecor Therapeutics - ARECOR GRANTED EUROPEAN PATENTS
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
Announcement